Should future studies reveal a significant relationship between FOXA1 loss and gender, the fact that FOXA1 has been described as a “master” of steroid receptor function in malignancy (reviewed in [37]) indicates further studies of the relationship between FOXA1 expression and gender in bladder cancer are warranted. The gene discussed is FOXA1; the disease is urinary bladder carcinoma.